Brown Miller Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Hold
2,970
0.15% 114
2026
Q1
$667K Hold
2,970
0.19% 90
2025
Q4
$715K Hold
2,970
0.2% 83
2025
Q3
$813K Hold
2,970
0.23% 76
2025
Q2
$766K Hold
2,970
0.24% 77
2025
Q1
$665K Hold
2,970
0.23% 83
2024
Q4
$679K Hold
2,970
0.26% 71
2024
Q3
$725K Hold
2,970
0.28% 64
2024
Q2
$569K Hold
2,970
0.24% 73
2024
Q1
$588K Hold
2,970
0.26% 71
2023
Q4
$511K Hold
2,970
0.26% 76
2023
Q3
$439K Hold
2,970
0.25% 77
2023
Q2
$649K Hold
2,970
0.35% 58
2023
Q1
$650K Hold
2,970
0.38% 59
2022
Q4
$618K Hold
2,970
0.39% 59
2022
Q3
$648K Hold
2,970
0.46% 54
2022
Q2
$622K Hold
2,970
0.42% 57
2022
Q1
$720K Hold
2,970
0.42% 57
2021
Q4
$773K Hold
2,970
0.44% 56
2021
Q3
$782K Hold
2,970
0.49% 54
2021
Q2
$732K Hold
2,970
0.47% 52
2021
Q1
$576K Hold
2,970
0.41% 57
2020
Q4
$631K Buy
+2,970
New +$592K 0.47% 54

Other funds holding RMD

Brown Miller Wealth Management's RMD Position: Q2 2026 in Review

Brown Miller Wealth Management held its ResMed (RMD) position steady in Q2 2026 at 2,970 shares worth $579K. The position accounts for 0.15% of the portfolio, ranked #114.

Brown Miller Wealth Management first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $813K in Q3 2025. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Brown Miller Wealth Management held 2,970 shares of ResMed worth $579K as of Q2 2026.
  • Brown Miller Wealth Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.15% of Brown Miller Wealth Management's portfolio in Q2 2026, its #114 holding.
  • Brown Miller Wealth Management first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • Brown Miller Wealth Management's ResMed position peaked at $813K in Q3 2025.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.